Finding 1241638 (2021-011)

Material Weakness Repeat Finding
Requirement
I
Questioned Costs
-
Year
2021
Accepted
2026-11-04

AI Summary

  • Core Issue: CHCC failed to verify vendor exclusions before entering into covered transactions, violating 2 CFR 180.300.
  • Impacted Requirements: Noncompliance with federal regulations on internal controls and suspension/debarment verification.
  • Recommended Follow-Up: Revise policies to ensure compliance with 2 CFR 180.300 for all vendors in covered transactions.

Finding Text

Finding No. 2021-011 - Procurement and Suspension and Debarment Identification of the federal program: Federal Agency: Department of Health and Human Services - Centers for Diseases and Control Prevention (HHS-CDC) AL Program: 93.323 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) Award Number: NU50CK000499-01 Criteria or specific requirement (including statutory, regulatory or other citation): In accordance with 2 CFR 200.303(a), the recipient and subrecipient must establish, document, and maintain effective internal control over the Federal award that provides reasonable assurance that the recipient or subrecipient is managing the Federal award in compliance with the Federal statutes, regulations, and the terms and conditions of the Federal award. Additionally, in accordance with 2 CFR 180.300, entities that enter into covered transactions must verify that the person with whom they intend to do business is not excluded or disqualified by: (a) Checking SAM.gov Exclusions; or (b) Collecting a certification from that person; or (c) Adding a clause or condition to the covered transaction with that person. Lastly, according to 2 CFR 180.200 (b) (1), a procurement transaction is considered a covered transaction if the contract amount is expected to equal or exceed $25,000. Condition: CHCC did not verify whether a person or a vendor is excluded or disqualified pursuant to the requirements of 2 CFR 180.300 prior to entering covered transactions. Cause: CHCC’s current policy or procedure for suspension and debarment monitoring only applies to newly contracted persons or vendors under a covered transaction, thus not pursuant to the requirements or provisions of 2 CFR § 180.300. Effect or potential effect: CHCC is in noncompliance with applicable Suspension and Debarment regulations. Questioned Costs: $352,470 The questioned cost of $352,470 is based on current-year expenditures for all covered transactions entered into during the year. Context: For 10 (or 100%) out of 10 covered transactions approved during the year, CHCC did not verify whether a person or a vendor is excluded or disqualified pursuant to the requirements of 2 CFR 180.300 prior to entering into a contract. Identification as a repeat finding, if applicable: This is not a repeat finding. Recommendation: CHCC should revise or update their policies and procedures for monitoring suspension and debarment status of each vendor of covered transactions. These should be reflective of the requirements set by 2 CFR 180.300. Views of Responsible Officials: CHCC concurs with the compliance finding concerning the absence of documented, contemporaneous suspension and debarment verification but respectfully disagrees with the questioned costs of $352,470. Under 2 CFR 200.516(b)(5), the effect of an audit finding should establish a clear and logical link between the identified condition and its actual or potential impact. Although CHCC did not retain evidence that the vendors’ exclusion status was verified before entering into the covered transactions, the historical SAM.gov Exclusions reports confirm that none of the vendors were suspended, debarred, or otherwise excluded during the relevant procurement periods. Accordingly, the procedural deficiency did not result in an award to an ineligible vendor. Additionally, 2 CFR 200.516(b)(6) requires questioned costs to be identified and their computation explained. The $352,470 represents the total expenditure under the seven covered transactions rather than costs demonstrated to be unallowable, unsupported, unreasonable, or incurred with an excluded vendor. The expenditures were supported, incurred for authorized program purposes, and resulted in goods or services received by CHCC. CHCC Division Grants and Financial Integrity (DGFI), updated our Suspension and Debarment procedure to comply with 2 CFR 180.300. Auditor Response: In accordance with 2 CFR 200.1(1)(i)(ii), questioned cost means an amount, expended or received from a Federal award, that is the auditor’s judgment: i. Is noncompliant or suspected noncompliant with Federal statutes, regulations or the terms and conditions of the Federal award; ii. At the time of the audit, lacked adequate documentation to support compliance. Additionally, in accordance with 2 CFR 200.1(2), the amount calculated in (1)(ii) is as if the portion of a transaction that lacked adequate documentation were confirmed noncompliant. Lastly, in accordance with 2 CFR 200.1(6), questioned costs are not improper payments until reviewed and confirmed to be improper payments. When audit procedures were performed, no documentation was provided to support that suspension and debarment monitoring procedures were conducted in accordance with 2 CFR 180.300. Accordingly, we retain the questioned costs.

Corrective Action Plan

Finding No.: 2021-011 AL Program: 93.323 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) Area: Procurement Suspension and Debarment Questioned Costs: $352,470 Contact Person(s): Program Manager, Procurement, DGFI Corrective Action Plan: CHCC concurs with the compliance finding concerning the absence of documented, contemporaneous suspension and debarment verification but respectfully disagrees with the questioned costs of $352,470. Under 2 CFR 200.516(b)(5), the effect of an audit finding should establish a clear and logical link between the identified condition and its actual or potential impact. Although CHCC did not retain evidence that the vendors’ exclusion status was verified before entering into the covered transactions, the historical SAM.gov Exclusions reports confirm that none of the vendors were suspended, debarred, or otherwise excluded during the relevant procurement periods. Accordingly, the procedural deficiency did not result in an award to an ineligible vendor. Additionally, 2 CFR 200.516(b)(6) requires questioned costs to be identified and their computation explained. The $352,470 represents the total expenditure under the seven covered transactions rather than costs demonstrated to be unallowable, unsupported, unreasonable, or incurred with an excluded vendor. The expenditures were supported, incurred for authorized program purposes, and resulted in goods or services received by CHCC. CHCC Division Grants and Financial Integrity (DGFI), updated our Suspension and Debarment procedure to comply with 2 CFR 180.300. Responsible Official: Director of Procurement and Supply, Director of DGFI and Chief Financial Officer Proposed Completion Date: 09/30/2026

Categories

Procurement, Suspension & Debarment Subrecipient Monitoring

Other Findings in this Audit

  • 1241631 2021-004
    Material Weakness Repeat
  • 1241632 2021-005
    Material Weakness Repeat
  • 1241633 2021-006
    Material Weakness Repeat
  • 1241634 2021-007
    Material Weakness Repeat
  • 1241635 2021-008
    Material Weakness Repeat
  • 1241636 2021-009
    Material Weakness Repeat
  • 1241637 2021-010
    Material Weakness Repeat
  • 1241639 2021-012
    Material Weakness Repeat
  • 1241640 2021-013
    Material Weakness Repeat
  • 1241641 2021-014
    Material Weakness Repeat

Programs in Audit

ALN Program Name Expenditures
93.498 PROVIDER RELIEF FUND AND AMERICAN RESCUE PLAN (ARP) RURAL DISTRIBUTION $5.21M
21.027 CORONAVIRUS STATE AND LOCAL FISCAL RECOVERY FUNDS $5.01M
97.036 DISASTER GRANTS - PUBLIC ASSISTANCE (PRESIDENTIALLY DECLARED DISASTERS) $3.63M
10.557 WIC SPECIAL SUPPLEMENTAL NUTRITION PROGRAM FOR WOMEN, INFANTS, AND CHILDREN $3.62M
93.268 IMMUNIZATION COOPERATIVE AGREEMENTS $3.51M
93.323 EPIDEMIOLOGY AND LABORATORY CAPACITY FOR INFECTIOUS DISEASES (ELC) $1.92M
93.243 SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES PROJECTS OF REGIONAL AND NATIONAL SIGNIFICANCE $1.02M
93.354 PUBLIC HEALTH EMERGENCY RESPONSE: COOPERATIVE AGREEMENT FOR EMERGENCY RESPONSE: PUBLIC HEALTH CRISIS RESPONSE $1.00M
93.870 MATERNAL, INFANT AND EARLY CHILDHOOD HOME VISITING GRANT $869,181
15.875 ECONOMIC, SOCIAL, AND POLITICAL DEVELOPMENT OF THE TERRITORIES $687,143
93.136 INJURY PREVENTION AND CONTROL RESEARCH AND STATE AND COMMUNITY BASED PROGRAMS $596,181
93.104 COMPREHENSIVE COMMUNITY MENTAL HEALTH SERVICES FOR CHILDREN WITH SERIOUS EMOTIONAL DISTURBANCES (SED) $528,358
93.116 PROJECT GRANTS AND COOPERATIVE AGREEMENTS FOR TUBERCULOSIS CONTROL PROGRAMS $462,618
93.982 MENTAL HEALTH DISASTER ASSISTANCE AND EMERGENCY MENTAL HEALTH $438,257
93.889 NATIONAL BIOTERRORISM HOSPITAL PREPAREDNESS PROGRAM $432,556
93.994 MATERNAL AND CHILD HEALTH SERVICES BLOCK GRANT TO THE STATES $422,872
93.236 GRANTS TO STATES TO SUPPORT ORAL HEALTH WORKFORCE ACTIVITIES $400,328
93.217 FAMILY PLANNING SERVICES $343,159
97.088 DISASTER ASSISTANCE PROJECTS $341,416
93.069 PUBLIC HEALTH EMERGENCY PREPAREDNESS $337,474
93.959 BLOCK GRANTS FOR PREVENTION AND TREATMENT OF SUBSTANCE ABUSE $328,371
93.898 CANCER PREVENTION AND CONTROL PROGRAMS FOR STATE, TERRITORIAL AND TRIBAL ORGANIZATIONS $290,825
93.251 EARLY HEARING DETECTION AND INTERVENTION $240,262
93.665 EMERGENCY GRANTS TO ADDRESS MENTAL AND SUBSTANCE USE DISORDERS DURING COVID-19 $214,228
93.377 PREVENTION AND CONTROL OF CHRONIC DISEASE AND ASSOCIATED RISK FACTORS IN THE U.S. AFFILIATED PACIFIC ISLANDS, U.S. VIRGIN ISLANDS, AND P. R. $179,144
93.788 OPIOID STR $168,753
93.912 RURAL HEALTHCARE SERVICES PROGRAMS $147,842
93.958 BLOCK GRANTS FOR COMMUNITY MENTAL HEALTH SERVICES $143,060
93.165 GRANTS TO STATES FOR LOAN REPAYMENT $125,000
93.817 HOSPITAL PREPAREDNESS PROGRAM (HPP) EBOLA PREPAREDNESS AND RESPONSE ACTIVITIES $123,359
10.855 DISTANCE LEARNING AND TELEMEDICINE GRANTS $120,717
93.504 FAMILY TO FAMILY HEALTH INFORMATION CENTERS $119,371
93.110 SPECIAL PROJECTS OF REGIONAL AND NATIONAL SIGNIFICANCE $69,403
93.103 FOOD AND DRUG ADMINISTRATION RESEARCH $45,076
93.917 HIV CARE FORMULA GRANTS $44,846
93.150 PROJECTS FOR ASSISTANCE IN TRANSITION FROM HOMELESSNESS (PATH) $43,612
93.991 PREVENTIVE HEALTH AND HEALTH SERVICES BLOCK GRANT $41,888
93.314 EARLY HEARING DETECTION AND INTERVENTION INFORMATION SYSTEM (EHDI-IS) SURVEILLANCE PROGRAM $26,630
93.946 COOPERATIVE AGREEMENTS TO SUPPORT STATE-BASED SAFE MOTHERHOOD AND INFANT HEALTH INITIATIVE PROGRAMS $5,817
16.575 CRIME VICTIM ASSISTANCE $5,696
93.644 ADULT MEDICAID QUALITY: IMPROVING MATERNAL AND INFANT HEALTH OUTCOMES IN MEDICAID AND CHIP $3,089
93.495 COMMUNITY HEALTH WORKERS FOR PUBLIC HEALTH RESPONSE AND RESILIENT $732